ArticleJournal of clinical medicine2020

Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016.

Min-Hao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.